BCAL Diagnostics Limited (ASX:BDX)
0.115
-0.005 (-4.17%)
Mar 9, 2026, 3:21 PM AEST
BCAL Diagnostics Revenue
BCAL Diagnostics had revenue of 1.27M AUD in the half year ending December 31, 2025, a decrease of -31.64%. This brings the company's revenue in the last twelve months to 2.54M, down -1.26% year-over-year. In the fiscal year ending June 30, 2025, BCAL Diagnostics had annual revenue of 2.65M, down -13.01%.
Revenue (ttm)
2.54M
Revenue Growth
-1.26%
P/S Ratio
16.71
Revenue / Employee
n/a
Employees
n/a
Market Cap
42.40M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| INOVIQ | 2.10M |
| Microba Life Sciences | 14.90M |
| Cryosite | 15.75M |
| Rhythm Biosciences | 1.65M |
| Genetic Signatures | 19.94M |
| Imagion Biosystems | 73.03K |
| Monash IVF Group | 269.39M |
| Genetic Technologies | 9.17M |